City

Sacramento (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

University of California, Davis (1)

Collaborator

Janssen, LP (1)

National Cancer Institute (NCI) (1)

Intervention

niraparib (1)

niraparib tosylate monohydrate (1)

radical prostatectomy (1)

Study Documents

Intervention Type

drug (1)

procedure (1)

Funder Type

Other (1)

Study Type

Interventional (1)

fancl gene mutation

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

Recruiting

ATM Gene Mutation
+16 more

Niraparib
+2 more

Sacramento, California

University of California Davis Comprehensive Cancer Center

Oct 27, 2022